Neutralizing Activity | List of Frontiers open access articles

Brief Research Report

Published on 21 Dec 2022

Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia

in Vaccines and Molecular Therapeutics

María I. Zapata-Cardona
Lizdany Flórez-Álvarez
Tulio J. Lopera
Mateo Chvatal-Medina
Wildeman Zapata-Builes
Francisco J. Diaz
Wbeimar Aguilar-Jimenez
Natalia Taborda
Juan C. Hernandez
Maria T. Rugeles

Frontiers in Immunology

doi 10.3389/fimmu.2022.1102384

3,059 views
2 citations

Original Research

Published on 27 Nov 2025

Establishment of rapid saturation mutagenesis and screening methods for improving the neutralizing activity of monoclonal antibodies

in Vaccines and Molecular Therapeutics

Xi Wu
Lijie Wang
Chenchen He
Yanru Shen
Youchun Wang
Weijin Huang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1722831

1,673 views

Original Research

Published on 15 Jun 2022

Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients

in Vaccines and Molecular Therapeutics

Hye Kyung Lee
Ludwig Knabl
Mary Walter
Ludwig Knabl
Yuhai Dai
Magdalena Füßl
Yasemin Caf
Claudia Jeller
Philipp Knabl
Martina Obermoser

Frontiers in Immunology

doi 10.3389/fimmu.2022.916686

6,816 views
34 citations

Original Research

Published on 10 Feb 2022

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2

in Infectious Diseases – Surveillance, Prevention and Treatment

Kei Miyakawa
Sundararaj Stanleyraj Jeremiah
Yutaro Yamaoka
Takahiko Koyama
Reitaro Tokumasu
Michiharu Kudo
Hideaki Kato
Akihide Ryo

Frontiers in Medicine

doi 10.3389/fmed.2022.811004

4,105 views
7 citations

Original Research

Published on 17 Apr 2024

High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection

in Viral Immunology

Hitoshi Kawasuji
Yoshitomo Morinaga
Kentaro Nagaoka
Hideki Tani
Yoshihiro Yoshida
Hiroshi Yamada
Yusuke Takegoshi
Makito Kaneda
Yushi Murai
Kou Kimoto

Frontiers in Immunology

doi 10.3389/fimmu.2024.1377014

3,241 views
8 citations

Original Research

Published on 05 Feb 2024

Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva

in Vaccines and Molecular Therapeutics

Stephan Winklmeier
Heike Rübsamen
Ceren Özdemir
Paul R. Wratil
Gaia Lupoli
Marcel Stern
Celine Schneider
Katharina Eisenhut
Samantha Ho
Hoi Kiu Wong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1330864

4,593 views
13 citations

Technology and Code

Published on 17 Jul 2025

Defining criteria for broadly neutralizing HIV antibodies

in Viral Immunology

Elizabeth-Sharon David-Fung
Katherine A. Belobrajdic
Jennifer P. Macke
Corey R. Quackenbush
Kumkum Ganguly
Jennifer L. Mamrosh

Frontiers in Immunology

doi 10.3389/fimmu.2025.1624020

3,296 views

Original Research

Published on 14 Aug 2023

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant

in Clinical and Diagnostic Microbiology and Immunology

Kun Wen
Jian-Piao Cai
Xiaodi Fan
Xiaojuan Zhang
Cuiting Luo
Kai-Ming Tang
Huiping Shuai
Lin-Lei Chen
Ricky Ruiqi Zhang
Jianwen Situ

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1213806

5,318 views
6 citations

Original Research

Published on 11 Mar 2022

Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees

in Viral Immunology

Micaela Garziano
Olga Utyro
Mariacristina Poliseno
Teresa Antonia Santantonio
Irma Saulle
Sergio Strizzi
Sergio Lo Caputo
Mario Clerici
Andrea Introini
Mara Biasin

Frontiers in Immunology

doi 10.3389/fimmu.2022.820250

6,199 views
23 citations

Original Research

Published on 24 May 2019

Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity

in Virology

Dai Zhang
Sen Zou
Yuanyuan Hu
Jiali Hou
Xintao Hu
Li Ren
Liying Ma
Xiang He
Yiming Shao
Kunxue Hong

Frontiers in Microbiology

doi 10.3389/fmicb.2019.01096

4,587 views
8 citations

Clinical Trial

Published on 23 Jan 2024

An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5

in Viral Immunology

Stephen Varvel
Marzena Galdzicka
Stephanie Nystrom
Hong Liu
Ge Chen
Izabela Ragan
Shahrokh Shabahang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1334250

2,243 views

Original Research

Published on 25 Sep 2017

Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein

in Vaccines and Molecular Therapeutics

Denicar Lina Nascimento Fabris Maeda
Milene Tavares Batista
Lennon Ramos Pereira
Mariana de Jesus Cintra
Jaime Henrique Amorim
Camila Mathias-Santos
Sara Araújo Pereira
Silvia Beatriz Boscardin
Sandriana dos Ramos Silva
Eliana L. Faquim-Mauro

Frontiers in Immunology

doi 10.3389/fimmu.2017.01175

7,528 views
37 citations

Brief Research Report

Published on 18 Mar 2024

Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan

in Vaccines and Molecular Therapeutics

Tianchen Zhao
Yuta Tani
Chieko Makino-Okamura
Morihito Takita
Chika Yamamoto
Eiki Kawahara
Toshiki Abe
Sota Sugiura
Hiroki Yoshimura
Taiga Uchiyama

Frontiers in Immunology

doi 10.3389/fimmu.2024.1337520

3,544 views
3 citations

Original Research

Published on 04 Mar 2022

Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients

in Vaccines and Molecular Therapeutics

Louise Benning
Katrin Klein
Christian Morath
Marie Bartenschlager
Heeyoung Kim
Mirabel Buylaert
Marvin Reineke
Maximilian Töllner
Christian Nusshag
Florian Kälble

Frontiers in Immunology

doi 10.3389/fimmu.2022.840136

4,263 views
21 citations

Original Research

Published on 16 May 2023

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients

in Clinical and Diagnostic Microbiology and Immunology

Takahiro Tomiyama
Rigel Suzuki
Noboru Harada
Tomokazu Tamura
Katsuya Toshida
Yukiko- Kosai-Fujimoto
Takahiro Tomino
Shohei Yoshiya
Yoshihiro Nagao
Kazuki Takeishi

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1197349

3,468 views
9 citations

Original Research

Published on 13 Sep 2024

Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice

in Vaccines and Molecular Therapeutics

Gabriela M. Escalante
Ivana G. Reidel
Lorraine Z. Mutsvunguma
Simeon Cua
Brenda A. Tello
Esther Rodriguez
Mafalda A. Farelo
Cloe Zimmerman
Murali Muniraju
He Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445209

5,892 views
6 citations

Articles

Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia

Establishment of rapid saturation mutagenesis and screening methods for improving the neutralizing activity of monoclonal antibodies

Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2

High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection

Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva

Defining criteria for broadly neutralizing HIV antibodies

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant

Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees

Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity

An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5

Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein

Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan

Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients

Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice